Heron Therapeutics is trading at $0.38, up 10.10% on October 5, 2026; market coverage linked the earlier gain to broader equities rising after weaker-than-expected September payrolls eased concerns about further Federal Reserve rate hikes. - No clear company-specific announcement explaining the October 5 move surfaced in available coverage. - Heron recently announced a licensing agreement, but the cited report dates it to September 29, so it does not establish the reason for today’s gain.